Skip to main content
. Author manuscript; available in PMC: 2019 Apr 10.
Published in final edited form as: Value Health. 2018 Aug 30;21(12):1357–1364. doi: 10.1016/j.jval.2018.06.003

Table 5.

Subgroup analysis.

Adjusted Cost Difference
for Intervention vs.
Control*
Adjusted QALY
Difference for
Intervention vs. Control*
Adjusted SBP
Difference for
Intervention vs.
Control*


N Mean (95% CI) Mean (95% CI) ICER 95%CI** Mean (95% CI) ICER 95%CI**

Age
≥60 years 558 227.93 (105.87, 349.99) 0.037 (−0.01, 0.08) 6160.27 (2862.48 to 16543.90) −5.02 (−9.48, −0.57) 45.40 (20.77 to 99.53)
<60 years 874 90.56 (10.88, 170.25) 0.042 (0.01, 0.08) 2156.19 (352.09 to 4669.80) −5.11 ( −10.57, 0.34) 17.72 (2.98 to 35.88)
Sex
Men 660 110.55 (13.05, 208.06) 0.037 (0.01, 0.07) 2987.84 (242.03 to 7636.44) −3.44 (−9.08, 2.18) 32.14 (1.75 to 99.95)
Women 772 164.63 (71.85, 257.40) 0.05 (0.01, 0.09) 3292.60 (1978.58 to 8162.88) −6.41 (−11.40, −1.43) 25.68 (13.55 to 44.98)
Cardiovascular risk
High >20 857 125.40 (31.17, 219.62) 0.046 (0.01, 0.09) 2726.09 (993.01 to 6106.72) −6.59 ( −13.36, 0.16) 19.03 (8.27 to 49.69)
Not high <20 575 152.64 (61.33, 243.94) 0.033 (0.01, 0.06) 4625.45 (1977.64 to 10674.81) −5.42 ( −10.69, −0.15) 28.16 (15.69 to 73.69)
Body mass index
≥30 kg/m2 798 84.42 (−6.12, 174.95) 0.047 (0.01, 0.09) 1796.17 (−206.97 to 4250.66) −4.59 (−10.38, 1.18) 18.39 (−1.79 to 50.40)
<30 kg/m2 634 210.33 (117.85, 302.80) 0.035 (0.01, 0.07) 6009.43 (3273.01 to 17477.13) −5.65 (−10.08, −1.24) 37.23 (20.49 to 68.16)
Morisky score
Low adherence (0–5) 358 83.22 (−57.97, 224.40) 0.05 (0.001–0.10) 1664.40 (−1223.41 to 6095.28) −4.77 (−10.03, 0.47) 17.45 (−13.09 to 54.68)
Intermediate (6–7) 406 162.13 (21.26, 303.01) 0.07 (0.015–0.12) 2316.14 (565.43 to 11989.43) −8.60 (−13.88, −3.32) 18.85 (3.95 to 55.15)
High adherence (8) 420 147.03 (87.84, 206.21) 0.02 (−0.01–0.06) 7351.50 (1789.59 to 25628) −3.81 ( −9.90, 2.28) 38.59 (13.55 to 120.21)